Journal of Shandong University (Health Sciences) ›› 2020, Vol. 58 ›› Issue (12): 54-59.doi: 10.6040/j.issn.1671-7554.0.2020.0753

Previous Articles     Next Articles

Expression of P-glycoprotein in the colonic mucosa of ulcerative colitis patients and its clinical significance

FU Zhenmei1, MA Mingze2   

  1. 1. Department of Medical Imaging;
    2. Department of Infectious Diseases, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China
  • Published:2020-12-08

PDF (PC)

233

Abstract: Objective To detect the expression of P-glycoprotein(P-GP)in the colonic mucosa of patients with ulcerative colitis(UC)before and after hormonotherapy, explore its correlation with the peripheral endotoxin and D-lactic acid levels, and investigate its association with UC. Methods Previously untreated UC patients(n=102)and healthy controls(n=31)were selected. The expression of P-GP in the colonic mucosa of UC patients before and after treatment, and that of healthy controls were detected with immunohistochemistry. The peripheral endotoxin and D-lactic acid levels were detected with ELISA and ultraviolet spectrophotometry respectively. Results Before hormonotherapy, the peripheral endotoxin ［(0.67±0.58)vs(18.15±0.73), P<0.01］ and D-lactic acid level ［(1.75±1.25)vs(10.85±1.94), P<0.05］ of UC patients were higher than those of healthy controls, while the expression of P-GP was lower(P<0.05). Two months after hormonotherapy, the total positive rate and strong positive rate of UC patients were significantly higher than the rates before therapy(P<0.05). The peripheral endotoxin and D-lactic acid levels before and after hormonotherapy were negatively correlated with P-GP expression. Conclusion The impaired intestinal barrier and increased intestinal permeability in UC patients may be related to the low expression of P-GP in intestinal mucosa. The P-GP expression may be correlated with the pathogenesis of ulcerative colitis.

Key words: Ulcerative colitis, P-glycoprotein, Multidrug resistance gene, Intestinal mucosa barrier

CLC Number: 

  • R574
[1] 中华医学会消化病学分会炎症性肠病协作组.对我国炎症性肠病诊断治疗规范的共识意见[J]. 中华消化杂志, 2007, 27(8): 545-550.
[2] 许冬梅, 张源潮, 杨清锐. 多药耐药基因敲除小鼠结肠炎的免疫病理改变[J]. 中华消化杂志, 2005, 25(2): 71-74. XU Dongmei, ZHANG Yuanchao, YANG Qingrui. Pathological manifestion of MDR1 gene knockout mice related mice colitis[J]. Chinese Journal of Digestion, 2005, 25(2): 71-74.
[3] Burman S, Hoedt EC, Pottenger S, et al. An(Anti)-inflammatory microbiota: defining the role in inflammatory bowel disease? [J]. Dig Dis, 2016, 34(1-2): 64-71.
[4] Chu H, Khosravi A, Kusumawardhani IP, et al. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease [J]. Science, 2016, 352(6289): 1116-1120.
[5] Chung CS, Chang PF, Liao CH, et al. Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects [J]. Scand J Gastroenterol, 2016, 51(4):410-419.
[6] Collins SM. The intestinal microbiota in the irritable bowel syndrome [J]. Int Rev Neurobiol, 2016, 131: 247-261. doi:org/1016/bs.im.2016.08.003.
[7] Dior M, Delagreverie H, Duboc H, et al. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome [J]. Neurogastroenterol Motil, 2016, 28(9): 1330-1340.
[8] Farnood A, Naderi N, Moghaddam SJ, et al. The frequency of C3435T MDR1 gene polymorphism in Iranian patients with ulcerative colitis [J]. Int J Colorectal Dis, 2007, 22(9): 999-1003.
[9] Yacyshyn B, Maksymowych W, Bowen-Yacyshyn MB, et al. Differences in P-glycoprotein-170 expression and activity between Crohns disease and ulcerative colitis [J]. Hum Immunol, 1999, 60(8): 677-687
[10] Fiedler T, Büning C, Reuter W, et al. Possible role of MDR1 two-locus genotypes for young-age onset?ulcerative colitis but not Crohns disease [J]. Eur J Clin Pharmacol, 2007, 63(10): 917-925.
[11] Filip AT, Balacescu O, Marian C, et al. Microbiota small RNAs in inflammatory bowel disease [J]. Gastrointestin Liver Dis, 2016, 25(4): 509-516.
[12] Wang XH, Li D, Zhang Y, et al. Costus root granules improve ulcerative colitis through regulation of TGF-β mediation of the PI3K/AKT signaling pathway [J]. Exp Ther Med, 2018, 15(5): 4477-4484.
[13] Xue Bing, Liang Linlang, Chen Keyan. Decreased Breg/Th17 ratio improved the prognosis of patients with ulcerative colitis [J]. Can J Gastroenterol Hepatol, 2018, 2018: 5760849. doi: 10.1155/2018/5760849.
[14] Dominika Gbska, Dominika Guzek, Gustaw lech. Nutritional status of men with ulcerative colitis in remission in a pair-matched case-control study [J]. J Clin Med, 2018, 7(11): 438.
[15] Lauren E. Hudson, Sarah E, et al. Gleaning insights from fecal microbiota transplantation and probiotic studies for the rational design of combination microbial therapies [J]. Clin Microbiol Rev, 2017, 30(1): 191-231.
[16] P. Kump, P. Wurm, H. P. Gröchenig, et al. The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis [J]. Aliment Pharmacol Ther, 2018, 47(1): 67-77.
[17] Bui K, She F, Zhou D et al. The effect of quinidine, a strong P-glycoprotein inhibitor, on the pharmacokinetics and central nervous system distribution of naloxegol [J]. J Clin Pharmacol, 2016, 56(4): 497-505.
[18] Choi JY, Song JS, Lee M et al. P-Glycoprotein, not BCRP, limits the brain uptake of [18F] mefway in rodent brain [J]. Mol Imaging Biol, 2016, 18(2): 267-273.
[19] Han L, Ma YM, An L et al. Non-alkaloids extract from Stemona sessilifolia enhances the activity of chemotherapeutic agents through P-glycoprotein-mediated multidrug-resistant cancer cells [J]. Natural Product Research, 2016, 30(10): 1186-1189.
[20] Hofman J, Kucera R, Neumanova Z, et al. Placental passage of olomoucine II, but not purvalanol A, is affected by p-glycoprotein(ABCB1), breast cancer resistance protein(ABCG2)and multidrug resistance-associated proteins(ABCCs)[J]. Xenobiotica, 2016, 46(5): 416-423.
[21] Kansal A, Tripathi D, Rai MK, et al. Persistent expression and function of P-glycoprotein on peripheral blood lymphocytes identifies corticosteroid resistance in patients with systemic lupus erythematosus [J]. Clin Rheumatol, 2016, 35(2): 341-349.
[22] Kumar A, Mishra J, Chopra K, et al. Possible role of P-glycoprotein in the neuroprotective mechanism of berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction [J]. Psychopharmacology, 2016, 233(1): 137-152.
[23] Liu JS, He YJ, Zhang J, et al. Functionalized nanocarrier combined seizure-specific vector with P-glycoprotein modulation property for antiepileptic drug delivery [J]. Biomaterials, 2016, 74: 64-76. doi: 10.1016/j.biomaterials.2015.09.041.
[24] Liu J, Wang M, Zhang XL, et al. CIP2A is associated with multidrug resistance in cervical adenocarcinoma by a P-glycoprotein pathway [J]. Tumour Biol, 2016, 37(2): 2673-2682.
[25] Marcos Prieto HM, Perez Corte D, Pinero Perez MC, et al. Acute pancreatitis secondary to partial multidrug resistance 3 p-glycoprotein deficit [J]. Gastroenterol Hepatol, 2016, 39(7): 465.
[1] GE Li-Juan, JIN Rui-Feng, WANG Ji-Wen, HU Xin-Sheng, LIKun. Association between the C1236T polymorphism in multi-drug resistance gene 1 and response to antiepileptic drug treatment in epileptic patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 99-102.
[2] CHE Qian-hong, GUO Jia-qi . Effects of the immune enteral nutrition combined with drug in treatment of ulcerative colitis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(7): 75-78.
[3] LI Xiao, HAO Hong-sheng. Baron index predicts mucosal healing of ulcerative colitis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(12): 67-69.
[4] LI Hai-su, YANG Chong-mei. Therapeutic effect of DPP-4 inhibitor on ulcerative colitis in mice [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(12): 29-33.
[5] LI Ling, CHEN Yong, YANG Chong-mei. Correlation study of single nucleotide polymorphism of multiple
drug resistance 1 and ulcerative colitis prednisone sensitivity [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(5): 99-102.
[6] LIU Sheng-nan, LU Xue-feng, SUN Na, ZHENG Xue-ting, LI Qian-qian. Toll-like receptors 2 and 4 and nuclear factor-ΚB in colonic mucosa of
ulcerative colitis: expression and clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 60-.
[7] LI Mei1,2, GAO Yan-jing1, CUI Xiang-hua1， XU Yong-mei3. Expression and clinical significance of EP2 prostanoid receptor in
colon mucosa of ulcerative colitis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(11): 79-83.
[8] MENG Xian-yi, ZHANG Yun, WU Zhen-zhou. Therapeutic effect of tylophorine analog DCB3503 on
TNBS-induced ulcerative colitis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(10): 81-.
[9] JIANG Na.

Effects of olsalazine in combination with diammonium glycyrrhizinate on lipid peroxidation and IL-1β levels in patients with ulcerative colitis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(9): 114-116.

[10] WANG Zhi-qiang1，2, YU Zhen-hai2, YUAN Fang-shu1. Effect of Bifidobacterium on expressions of TLR2, TLR4 and NF-κB  genes in the intestinal mucosa of rats with ulcerative colitis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(5): 10-14.
[11] WANG Kai-lei， LI Le-ping， JING Chang-qing. Establishment and comparison of two human multidrug-resistant colorectal carcinoma cell lines [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 75-.
[12] MA Ming-ze, ZHANG An-zhong，KUAI Jing-hua，YANG Chong-mei. Detection of serum food allergen-specific IgG and impact of allergic food  elimination on the treatment of ulcerative colitis patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(1): 86-89.
[13] KONG Shuai， LI Leping， JING Changqing, WANG Feng. The reversal effect on MDR1 gene-mediated multidrug resistance in human colon carcinoma LoVo/5-Fu cells by RNA interference [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(6): 80-83.
[14] GE Li-Juan, JIN Rui-Feng, WANG Ji-Wen, HU Xin-Sheng, LIKun. Association between the C1236T polymorphism in multi-drug resistance gene 1 and response to antiepileptic drug treatment in epileptic patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(6): 99-102.
[15] WANG Bo,WANG Zhi-yun,WANG Cheng-wei,WANG Zhi-gang,ZHANG Yuan,ZHANG Qing-lin. Targeted killing effects of double suicide genes controlled by the MDR1 promoter on C6/ADR cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(1): 15-18.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd